These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19439721)

  • 1. Moving on to second-line therapies in pediatric MS: Immunosuppression with cyclophosphamide.
    Yeh EA; Weinstock-Guttman B
    Neurology; 2009 Jun; 72(24):2064-5. PubMed ID: 19439721
    [No Abstract]   [Full Text] [Related]  

  • 2. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O; Fernández V; De Ramón E
    J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide therapy in pediatric multiple sclerosis.
    Makhani N; Gorman MP; Branson HM; Stazzone L; Banwell BL; Chitnis T
    Neurology; 2009 Jun; 72(24):2076-82. PubMed ID: 19439723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis.
    Banwell B; Tremlett H
    Neurology; 2005 Mar; 64(5):778-9. PubMed ID: 15753408
    [No Abstract]   [Full Text] [Related]  

  • 5. The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosis.
    Jeffery DR
    J Neurol Sci; 2004 Aug; 223(1):41-6. PubMed ID: 15261559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapy of multiple sclerosis using cyclophosphamide with few side effects].
    Kornhuber HH; Mauch E
    Dtsch Med Wochenschr; 1986 Nov; 111(46):1778. PubMed ID: 3780443
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multiple sclerosis--current status of therapy].
    Reichel D; Kölmel HW
    Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive immunosuppression in multiple sclerosis.
    Zaffaroni M; Ghezzi A; Comi G
    Neurol Sci; 2006 Mar; 27 Suppl 1():S13-7. PubMed ID: 16708175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks.
    Rinaldi L; Perini P; Calabrese M; Gallo P
    Neurol Sci; 2009 Oct; 30 Suppl 2():S171-3. PubMed ID: 19882369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressants and multiple sclerosis].
    Ruiz-Peña JL; Izquierdo-Ayuso G
    Rev Neurol; 2002 Aug 16-31; 35(4):373-80. PubMed ID: 12235571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.
    Wiendl H; Hohlfeld R
    Neurology; 2009 Mar; 72(11):1008-15. PubMed ID: 19289741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician.
    Boster A; Edan G; Frohman E; Javed A; Stuve O; Tselis A; Weiner H; Weinstock-Guttman B; Khan O;
    Lancet Neurol; 2008 Feb; 7(2):173-83. PubMed ID: 18207115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating new insights into treatment optimisation in multiple sclerosis.
    Fazekas F; Kieseier BC
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S1-2. PubMed ID: 19200857
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon neutralizing antibodies in multiple sclerosis: a new perspective.
    Phillips JT
    Arch Neurol; 2010 Apr; 67(4):386-7. PubMed ID: 20385901
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with cyclophosphamide in multiple sclerosis: the cons.
    Likosky WH
    Neurology; 1988 Jul; 38(7 Suppl 2):14-8. PubMed ID: 3290708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-specific immunosuppression and multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):629-34. PubMed ID: 9809379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glatiramer in the treatment of multiple sclerosis.
    Rizvi SA; Kim E; Moodie J
    Int J Nanomedicine; 2006; 1(3):283-9. PubMed ID: 17717969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intensive immunosuppressive treatment of chronic progressive multiple sclerosis].
    Hommes OR
    Ned Tijdschr Geneeskd; 1978 Oct; 122(41):1545-51. PubMed ID: 358004
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of children and adolescents with multiple sclerosis.
    Banwell B
    Expert Rev Neurother; 2005 May; 5(3):391-401. PubMed ID: 15938672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide-based combination therapies for autoimmunity.
    Perini P; Calabrese M; Rinaldi L; Gallo P
    Neurol Sci; 2008 Sep; 29 Suppl 2():S233-4. PubMed ID: 18690502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.